Basket | Login | Register

 
 
 
 

NorAD trial (coming soon)

Phase III trials

Scientific title

Noradrenergic Add-on Therapy With Guanfacine

Study sponsor

Imperial College London

Disease

People with a diagnosis of Alzheimer’s Disease

Phase

Phase III

Name of drug

Guanfacine

Link to full text

https://clinicaltrials.gov/ct2/show/NCT03116126

Please note that an accessible easy read version of this study is not yet available. The pharmaceutical company running this trial and a member of the European Working Group of People with Dementia are currently reviewing this document.

 

 
 

Last Updated: Wednesday 05 June 2019

 

 
  • Acknowledgements

    Alzheimer Europe's Clinical Trial Watch received funding under an operating grant from the European Union’s Health Programme (2014–2020).
  • European Union
 
 

Options